Is Latisse safe during breastfeeding?

Understanding Latisse and Breastfeeding Safety
Latisse, a popular treatment for enhancing eyelash growth, contains the active ingredient bimatoprost. While many new mothers may be eager to use this product to achieve fuller lashes, concerns about its safety during breastfeeding are prevalent.
Current Recommendations
The consensus among healthcare professionals is cautious. Although there is no explicit warning against using Latisse while breastfeeding, the lack of definitive studies on its effects during this period raises questions. The manufacturer advises exercising caution, as bimatoprost could potentially be excreted into breast milk. This uncertainty leads many experts to recommend avoiding any products that could be absorbed into the bloodstream and subsequently affect breast milk.
Expert Opinions
Some healthcare providers suggest that while the risk may be low, it is prudent to err on the side of caution. A conservative approach is often recommended, particularly for breastfeeding mothers who may be concerned about any substances entering their milk. The absence of a clear directive stating “do not use while breastfeeding” does not equate to a blanket endorsement of safety.
Conclusion
In summary, while Latisse does not have a direct contraindication for breastfeeding, the potential for bimatoprost to enter breast milk and the lack of comprehensive studies on its effects during lactation warrant a careful approach. Mothers considering Latisse should consult with their healthcare provider to weigh the benefits against any potential risks, ensuring the health and safety of both mother and child.

Can I use bimatoprost while breastfeeding?

Bimatoprost and breastfeeding
Bimatoprost eye drops are not thought to pass into breast milk or cause any side effects in breastfed babies.

Who cannot use Latisse?

Latisse should not be used by pregnant or nursing mothers or anyone under 18 years of age. Latisse is contraindicated for patients with sensitivity to bimatoprost or patients who are currently using intraocular pressure (IOP) lowering medications.

What is the downside of Latisse?

However, Latisse can cause some undesirable effects. Some people develop eye redness and irritation, or dark eyelid skin. These effects disappear after discontinuing the drug. Darkening of the iris (the colored portion of the eye) has also been reported, and this side effect cannot be reversed.

Can you get permanent eyeliner while breastfeeding?

The most important reason a pregnant or nursing mother should not have a permanent make up procedure, or any tattoo or piercing, is because there is always a chance of infection.

Can you use Latisse while breastfeeding?

Because many drugs are excreted in human milk, caution should be exercised when LATISSE™ is administered to a nursing woman. Safety and effectiveness in pediatric patients have not been established.

Is Latisse a prostaglandin?

Bimatoprost (Latisse) is a prostaglandin that’s used for people who need help with eyelash growth. Though unclear, it’s thought to increase the number of eyelash hairs that are growing. Bimatoprost (Latisse) is a liquid that you apply directly onto the edge of the upper eyelid where your eyelashes are.

How can I get my eyelashes done while pregnant?

They recommend asking your technician if she minds allowing you to have a break between eyes, or if it is possible to put the chair at an incline. One expecting mother explains that putting a pillow under her legs made the process more comfortable.

Can I use eyelash growth serum while breastfeeding?

As an eyelash serum it should also have low plasma and milk levels as such a small amount is applied topically. This will probably be ok to use while nursing, but there is no data in pregnancy so we would recommend avoiding its use during that time.

Why can’t I use Latisse while pregnant?

In the case of Latisse, animal studies showed that at the approximate equivalent of 41 times the human dose, mothers saw a decreased gestation period and fetal weight, while there was an increase in dead fetuses, fetal resorption, fetal mortality, and pup mortality.